Navigation Links
Young Babies at Risk of 'sudden Death' Syndrome While Seated: Study

Very young babies face a small risk of sudden death when seated, and not only when they are lying down, according to a study published online by Archives of Disease in Childhood , a British journal.

The findings are based on an analysis of cases of sudden, unexpected deaths that occurred among infants up to the age of 12 months in Quebec, Canada, between 1991 and 2000.

Of 508 fully investigated deaths, 17, or 3.3 percent, occurred in babies who had been placed in seats, most often in car seats. The relative risk was much higher among babies who were less than a month old.

The authors, led by Aurore Cote at the McGill University Health Center in Montreal, say the risk was relatively small and do not call car-seat safety into question.

But extra care should be taken for very young babies in any type of infant seat, they say.

Last December, a paper in the British Medical Journal (BMJ) by doctors at New Zealand's University of Auckland recommended that parents not let very young babies sleep unattended in standard car safety seats.

They examined the cases of 43 local babies who had turned "blue" from lack of oxygen and had needed medical attention.

Nine of these infants had been restrained in a car safety seat that was suitable for their age.

When the experts reconstructed the scenes, using the infant's own car seat, they found the baby's head was invariably flexed forward. Its jaw pressed down on its chest, which caused a narrowing of the upper airway and led to breathing difficulties.

Several factors could have aggravated their difficulties, the main one being that the infants were very young -- average age five weeks -- and were thus at a stage when head control was undeveloped.


'"/>




Page: 1

Related medicine news :

1. Young womens woes
2. Young womens woes
3. Zinc may enhance growth in Young sickle cell patients
4. Young women prone to heart attack
5. Blood Pressure Checks To Be Done For Children As Young As Age 3
6. The Harmful Effects Of Stress in Young Adults
7. Viagra Used More By Young Men
8. Young Smokers at Increased Risk Of Developing a Heart Attack
9. Calcium-rich Diet Good For Youngsters
10. Reconstituted Blood Better For Young Hearts
11. Young Patients On Antidepressants Found To Be Associated With Suicidal Tendencies
Post Your Comments:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... treated unfairly not only makes your blood boil i...o increase your chances of having a heart attack....00 senior civil servants working for the British g...s a part of the Whitehall Study II, the civil serv...
...ding to a small study, vertical work-stations, inc... shed up to 30 kg in weight every year. The vert... computer while simultaneously walking on a treadm... own choosing. Designed by the authors, the steel...
...mune, the company that has successfully sold flu v... 49 is now poised on the edge of another victory ....ut to approve the sale of FluMist targeting childr...ment comes at a time when the company is planning ...
...dy of 62 youngsters has revealed that low tar, low... heart as severely as regular cigarettes . All th...int in the journal Heart, were in their mid-twenti...d smoked low tar, low nicotine cigarettes for at l...
Other Medicine News:Health News:Heart Attack Risk Increased by Unfair Treatment 2Health News:walk and Work Desk Could Help Obese Workers to Shed Weight 2Health News:Influenza Vaccine FluMist To Be Approved In Younger Children As Well 2
(Date:9/5/2008)...a., Sept. 5 /PRNewswire-USNewswire/ -- The Florida...ly awarded Florida,Atlantic University researcher ... director of the Center for Molecular Biology and,... Science, and CHS,Resources LLC (CHS), $184,294 as...zation Assistance Grant program (SURECAG). SURECAG...
(Date:9/5/2008)...trates microRNAs Extracted From a Simple Blood Dra...l Biomarkers for a Wide Range of ...hnology, Rosetta Genomics is Currently Developing ...ancer, REHOVOT, Israel and JERSEY CITY, New Jerse...enomics, Ltd. (NASDQ: ROSG), a leader in,the devel...
(Date:9/4/2008)...shed in ,The Lancet, and Presented at ESC Congress...from a new international,study, the GISSI Heart Fa...omega-3 acid ethyl esters reduced all cause mortal...sons in patients with chronic heart,failure. These...ion of ,The,Lancet, and were presented at the Euro...
(Date:9/4/2008)...d Survival Data for Ipilimumab to be Presented, P...Medarex, Inc.,(Nasdaq: MEDX ) announced today tha...tigational anti-CTLA-4 antibody, in melanoma are s... 33rd Congress of the European Society,for Medical...in Stockholm.,Many of the following abstracts will...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3The Multiple Myeloma Research Consortium 28MMRC 29 and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multi 62 1The Multiple Myeloma Research Consortium 28MMRC 29 and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multi 62 2The Multiple Myeloma Research Consortium 28MMRC 29 and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multi 62 3The Multiple Myeloma Research Consortium 28MMRC 29 and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multi 62 4Romark Initiates Clinical Trial of Alinia 28R 29 for Chronic Hepatitis C in the United States 57 1Romark Initiates Clinical Trial of Alinia 28R 29 for Chronic Hepatitis C in the United States 57 2Romark Initiates Clinical Trial of Alinia 28R 29 for Chronic Hepatitis C in the United States 57 3Romark Initiates Clinical Trial of Alinia 28R 29 for Chronic Hepatitis C in the United States 57 4Strategic Diagnostics to Present at Two Upcoming Investor Conferences 52 1Strategic Diagnostics to Present at Two Upcoming Investor Conferences 52 2Strategic Diagnostics to Present at Two Upcoming Investor Conferences 52 3Strategic Diagnostics to Present at Two Upcoming Investor Conferences 52 4Strategic Diagnostics to Present at Two Upcoming Investor Conferences 52 5European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 1European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 2European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 3European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 4European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 5European EMEA Acceptance of Marketing Authorization Application Filing for SNT MC17 in Friedreichs Ataxia by Santhera 47 6
... 15, 2007 /PRNewswire-FirstCall/ --,Bristol-Myers ...he,efficacy and safety of ORENCIA(R) (abatacept) f...onal study in children with juvenile,idiopathic ar...to,one or more disease-modifying anti- rheumatic d... necrosis factor (TNF) antagonists.,The results de...
...7 /PRNewswire/ -- Telomerase Activation,Sciences, ...s of,the Pivotal 2005 Anti-Aging Trial of TA-65, t...asurable and positive anti-aging,benefits from a T...ults were found in those taking TA-65 across sever...in immune system function, -- Improvement in v...
Other Medicine Technology:Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07,Teleconference to Answer Questions About TA-65, Their Telomerase,Activator With Proven Age Management Benefits 2
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator.
Air-Charged Catheters make motility testing simpler than ever before. Disposable Latitude catheters set up in seconds and protect against cross-contamination. And with every sensor circumferential, A
Replacement Stopper for LATITUDE® Air-Charged Catheter
Medicine Products: